lncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium‑derived factor via miR‑93 to suppress cell proliferation in hepatocellular carcinoma

Li,Bin; Wei,Yajun; Ge,Qinli; Duan,Yucai; Guo,Ling

doi:10.3892/ol.2021.12521

lncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium‑derived factor via miR‑93 to suppress cell proliferation in hepatocellular carcinoma

Authors:
- Bin Li
- Yajun Wei
- Qinli Ge
- Yucai Duan
- Ling Guo
View Affiliations

Affiliations: Department of Gastroenterology, 96604 Military Hospital of The Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China, Department of Infectious Diseases, 96604 Military Hospital of The Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China, Department of Cardiology, The 940 Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China
Published online on: February 4, 2021 https://doi.org/10.3892/ol.2021.12521
Article Number: 260
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cancer ranks in the top 10 most common malignancies for both mortality rate and incidence worldwide. Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. It has been reported that long non‑coding RNA GABPB1 intronic transcript 1 (IT1) is downregulated in lung cancer and predicts poor survival. However, its role in live cancer remains unclear. Therefore, the present study aimed to investigate the role of GABPB1‑IT1 in HCC. A total of 64 patients with HCC (40 males and 24 females; range, 43‑67 years old; mean age=55.1±5.1 years) were enrolled at the 96604 Military Hospital of the Chinese People's Liberation Army between May 2012 and May 2014. The expression levels of GABPB1‑IT1 and microRNA (miR)‑93 in tumor and adjacent normal tissues were measured using quantitative PCR. A dual luciferase activity assay was performed to analyze the interaction between miR‑93 and GABPB1‑IT1. A Cell Counting Kit‑8 assay was used to analyze the effect of miR transfection on the proliferation of SNU‑398 cells. It was demonstrated that GABPB1‑IT1 can interact with miR‑93 in HCC cells, while overexpression of GABPB1‑IT1 and miR‑93 in HCC cells did not affect the expression of each other. GABPB1‑IT1 was downregulated in HCC tissues compared with paired non‑tumor tissues and predicted poor survival. Notably, overexpression of GABPB1‑IT1 in HCC cells led to upregulation of pigment epithelium‑derived factor (PEDF), a target of miR‑93. In addition, overexpression of GABPB1‑IT1 reduced the enhancing effects of miR‑93 on HCC cell proliferation. Therefore, GABPB1‑IT1 may upregulate PEDF through miR‑93 to suppress cell proliferation in HCC.

View Figures

View References

1	Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, et al: Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
3	Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M and Gores G: Hepatocellular carcinoma. Nat Rev Dis Primers. 2:160182016. View Article : Google Scholar : PubMed/NCBI
4	Janevska D, Chaloska-Ivanova V and Janevski V: Hepatocellular carcinoma: Risk factors, diagnosis and treatment. Open Access Maced J Med Sci. 3:732–736. 2015. View Article : Google Scholar : PubMed/NCBI
5	Negash AA, Olson RM, Griffin S and Gale M Jr: Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation. PLoS Pathog. 15:e10075932019. View Article : Google Scholar : PubMed/NCBI
6	Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H, Ma Z, Mitra B, Zhao G, Huang Y, et al: Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog. 15:e10076902019. View Article : Google Scholar : PubMed/NCBI
7	Shi L, Zhang W, Zou F, Mei L, Wu G and Teng Y: KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. BMC Cancer. 16:8152016. View Article : Google Scholar : PubMed/NCBI
8	Chen HC, Jeng YM, Yuan RH, Hsu HC and Chen YL: SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Ann Surg Oncol. 19:2011–2019. 2012. View Article : Google Scholar : PubMed/NCBI
9	Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ and Lee SH: PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene. 24:1477–1480. 2005. View Article : Google Scholar : PubMed/NCBI
10	Mattick JS and Makunin IV: Non-coding RNA. Hum Mol Genet. April 15;200 (Epub ahead of print). doi: 10.1093/hmg/ddl046.
11	Hauptman N and Glavac D: Long non-coding RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
12	Reddy KB: MicroRNA (miRNA) in cancer. Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
13	Qi P and Du X: The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 26:155–165. 2013. View Article : Google Scholar : PubMed/NCBI
14	Xie J, Xie G, Chen Q, Xu Z, Bai W and Chen M: Identification of a novel lncRNA GABPB1-IT1 that is downregulated and predicts a poor prognosis in non-small cell lung cancer. Oncol Lett. 18:838–845. 2019.PubMed/NCBI
15	Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015. View Article : Google Scholar : PubMed/NCBI
16	Jiang H, Bu Q, Zeng M, Xia D and Wu A: MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF. Urol Oncol. 37:150–157. 2019. View Article : Google Scholar : PubMed/NCBI
17	Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC and Wu CW: Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg. 203:426–435. 2006. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Higuchi T, Oshiro H, Zhang Z, Miyake K, Sugisawa N, Katsuya Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, et al: Osimertinib regresses an EGFR-mutant cisplatinum-resistant lung adenocarcinoma growing in the brain in nude mice. Transl Oncol. 12:640–645. 2019. View Article : Google Scholar : PubMed/NCBI
20	Sun X, Zheng G, Li C and Liu C: Long non-coding RNA Fer-1-like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo. Mol Med Rep. 19:685–692. 2019.PubMed/NCBI
21	Mann M, Wright PR and Backofen R: IntaRNA 2.0: Enhanced and customizable prediction of RNA-RNA interactions. Nucleic Acids Res. 45:W435–W439. 2017. View Article : Google Scholar : PubMed/NCBI
22	Hausser J and Zavolan M: Identification and consequences of miRNA-target interactions-beyond repression of gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
23	Forner A and Bruix J: Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 13:750–751. 2012. View Article : Google Scholar : PubMed/NCBI
24	Altekruse SF, Henley SJ, Cucinelli JE and McGlynn KA: Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 109:542–553. 2014. View Article : Google Scholar : PubMed/NCBI
25	Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X and Wang H: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 66:157–167. 2015. View Article : Google Scholar : PubMed/NCBI
26	Wang L, Yang G, Zhu X, Wang Z, Wang H, Bai Y, Sun P, Peng L, Wei W, Chen G, et al: miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion. Oncotarget. 8:82824–82834. 2017. View Article : Google Scholar : PubMed/NCBI
27	Wu J, Leontis NB, Zirbel CL, Bisaro DM and Ding B: A three-dimensional RNA motif mediates directional trafficking of Potato spindle tuber viroid from epidermal to palisade mesophyll cells in Nicotiana benthamiana. PLoS Pathog. 15:e10081472019. View Article : Google Scholar : PubMed/NCBI